- In September 2023, Enovis finalized its acquisition of LimaCorporate S.p.A., a prominent orthopedic implant manufacturer, for approximately EUR 800 million. This strategic move enhances Enovis's capabilities in providing innovative implant solutions and strengthens its position in the global orthopedic market
- In July 2023, Smith+Nephew introduced the REGENETEN Bioinductive Implant in India to address the growing demand for rotator cuff repair solutions. This implant is designed to enhance the healing process and improve outcomes for individuals undergoing rotator cuff surgeries
- In May 2023, Zimmer Biomet launched the Persona OsseoTi Keel Tibia, a new cementless knee implant. This innovative product allows surgeons the flexibility to decide whether cement is necessary during the procedure, depending on the patient's bone quality, thereby enhancing surgical options and patient outcomes in knee replacement surgeries
- In February 2023, CurvaFix introduced a smaller-diameter (7.5mm) intramedullary implant designed to simplify surgical procedures for small-boned patients. This implant offers strong and stable curved fixation, addressing the unique needs of this patient population and improving surgical outcomes
- In April 2022, The Orthopaedic Implant Company (OIC) obtained FDA approval for its High-Value Wrist Fracture Plating System. This milestone is expected to enhance OIC's global product portfolio and expand its offerings in the orthopedic market, underscoring the company's commitment to delivering innovative solutions for wrist fracture treatment
